Manatt Health Partner Rachel Sher spoke with MM+M about the Food and Drug Administration (FDA) user fee reauthorization bill, which would reauthorize all user fees for drugs, medical devices, generic drugs and biosimilars, as well as bolster the FDA’s work in reviewing the safety and efficacy ...